Hologic Q2 beats: revenue $1,018M, adj EPS $1.03; raises FY24 guidance; acquires Endomagnetics for $310M

HOLOGIC INC

2024-Q2 EPS reported $1.74 revenue$2,030,900,000

Q2 revenue $1,017.8M (down 0.8% YoY) exceeded guidance; GAAP diluted EPS $0.72, non-GAAP $1.03.
Organic revenue ex-COVID grew 4.9% constant currency; Diagnostics ex-COVID +9.8%, Surgical +7.4%.
Company raised full-year revenue midpoint in constant currency and EPS guidance on strong margins.
Agreed to acquire Endomagnetics Ltd for ~$310M, adding breast cancer surgery technologies.
Cash flow from operations $292.4M; cash generation remains strong.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.9

HOLOGIC INC reported the second quarter ended March 30, 2024 results: revenue $1,017.8 million, EPS $0.72. Guidance raised.

Period: the second quarter ended March 30, 2024
Revenue: $1,017.8 million
EPS: $0.72
Guidance: raised
Result: reported results

Exact text from the filing

Hologic Announces Financial Results for Second Quarter of Fiscal 2024 – Revenue of $1,017.8 Million, GAAP Diluted EPS of $0.72, and Non-GAAP Diluted EPS of $1.03; Revenue and Non-GAAP Diluted EPS Exceeded Guidance – – Total Company Organic Revenue Growth Excluding COVID-19 of 4.9% in Constant Currency; Against a 21.9% Prior Year Period Comparable – – Company Raises Full-Year Revenue Midpoint in Constant Currency and Raises EPS Guidance on Strong Margins

View on SEC.gov

710 earnings releases filed in the last 30 days. Browse all earnings releases →

Source: SEC EDGAR

accession 0001140361-24-024213

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.